A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions

Heart Failure

Interventions

DRUG

AZD9977

Randomized participants will receive oral dose of AZD9977.

DRUG

Placebo

Randomized participants will receive oral dose of matching placebo.

Trial Locations (1)

Research Site, Harrow